Expanding human immunodeficiency virus testing:whole society participation and multilevel promotion  

作　　者：Qing-Hai Hu Jun-Jie Xu Yong-Jun Jiang Hong Shang 

机构地区：[1]NHC Key Laboratory of AIDS Immunology(China Medical University),National Clinical Research Center for Laboratory Medicine,The First Affiliated Hospital of China Medical University,Shenyang,Liaoning 110001,China [2]Key Laboratory of AIDS Immunology,Chinese Academy of Medical Sciences,Shenyang,Liaoning 110001,China [3]Key Laboratory of AIDS Immunology of Liaoning Province,Shenyang,Liaoning 110001,China [4]Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,Hangzhou,Zhejiang 310003,China

出　　处：《Chinese Medical Journal》2021年第23期2773-2775,共3页中华医学杂志（英文版）

基　　金：the Mega-Projects of National Science Research for the 13th Five-Year Plan(No.2017ZX10201101);the National Natural Science Foundation of China(No.82073620).

摘　　要：Human immunodeficiency virus(HIV)testing is the only way to find people living with HIV(PLWH).Early diagnosis and early treatment of HIV can extend the life of PLWH and reduce the subsequent transmission of HIV.Therefore,HIV testing plays a crucial role in public health.The global scale of HIV testing has expanded significantly over the past 10 years.Of the estimated 37 million people with HIV worldwide,approximately 79%knew their HIV status in 2018,compared with 12%in 2005.By 2018,68.9%of PLWH in China had received a diagnosis.[1]This number is far from the target of 90%of PLWH knowing their HIV status,which is advocated in the implementation plan for containing the spread of HIV/acquired immuno-deficiency syndrome(AIDS)(2019–2022).[2]Expanding HIV testing has become an essential and challenging issue for China’s current HIV/AIDS prevention and control.

关 键 词：IMMUNODEFICIENCY prevention diagnosis 

分 类 号：R512.91[医药卫生—内科学]